关注
Daniel Ontaneda, MD PhD
Daniel Ontaneda, MD PhD
Cleveland Clinic Foundation, Professor of Neurology
在 ccf.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
D Ontaneda, AJ Thompson, RJ Fox, JA Cohen
The Lancet 389 (10076), 1357-1366, 2017
3522017
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
P Sati, J Oh, RT Constable, N Evangelou, CRG Guttmann, RG Henry, ...
Nature Reviews Neurology 12 (12), 714-722, 2016
3522016
Phase 2 trial of ibudilast in progressive multiple sclerosis
RJ Fox, CS Coffey, R Conwit, ME Cudkowicz, T Gleason, A Goodman, ...
New England Journal of Medicine 379 (9), 846-855, 2018
2772018
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
D Ontaneda, RJ Fox, J Chataway
The Lancet Neurology 14 (2), 208-223, 2015
2552015
Cell-based therapeutic strategies for multiple sclerosis
NJ Scolding, M Pasquini, SC Reingold, JA Cohen
Brain 140 (11), 2776-2796, 2017
1802017
Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study
BD Trapp, M Vignos, J Dudman, A Chang, E Fisher, SM Staugaitis, ...
The Lancet Neurology 17 (10), 870-884, 2018
1562018
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
D Ontaneda, E Tallantyre, T Kalincik, SM Planchon, N Evangelou
The Lancet Neurology 18 (10), 973-980, 2019
1512019
Measuring myelin repair and axonal loss with diffusion tensor imaging
RJ Fox, T Cronin, J Lin, X Wang, K Sakaie, D Ontaneda, SY Mahmoud, ...
American Journal of Neuroradiology 32 (1), 85-91, 2011
1492011
Progressive multiple sclerosis
D Ontaneda, RJ Fox
Current opinion in neurology 28 (3), 237-243, 2015
1062015
Multiple sclerosis: new insights in pathogenesis and novel therapeutics
D Ontaneda, M Hyland, JA Cohen
Annual review of medicine 63 (1), 389-404, 2012
1042012
T1‐/T2‐weighted ratio differs in demyelinated cortex in multiple sclerosis
K Nakamura, JT Chen, D Ontaneda, RJ Fox, BD Trapp
Annals of neurology 82 (4), 635-639, 2017
1022017
Diagnosis and management of progressive multiple sclerosis
G Macaron, D Ontaneda
Biomedicines 7 (3), 56, 2019
822019
Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) task force on clinical disability measures
D Ontaneda, N LaRocca, T Coetzee, RA Rudick
Multiple Sclerosis Journal 18 (8), 1074-1080, 2012
822012
Multiple sclerosis management during the COVID-19 pandemic
BP Moss, KR Mahajan, RA Bermel, K Hellisz, LH Hua, T Hudec, S Husak, ...
Multiple Sclerosis Journal 26 (10), 1163-1171, 2020
812020
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
RJ Fox, CS Coffey, ME Cudkowicz, T Gleason, A Goodman, EC Klawiter, ...
Contemporary clinical trials 50, 166-177, 2016
742016
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up
CM Hersh, TE Love, A Bandyopadhyay, S Cohn, C Hara-Cleaver, ...
Multiple Sclerosis Journal–Experimental, Translational and Clinical 3 (3 …, 2017
732017
Imaging as an outcome measure in multiple sclerosis
D Ontaneda, RJ Fox
Neurotherapeutics 14 (1), 24-34, 2017
692017
Management of acute exacerbations in multiple sclerosis
D Ontaneda, AD Rae-Grant
Annals of Indian Academy of Neurology 12 (4), 264-272, 2009
682009
Imaging outcome measures of neuroprotection and repair in MS: a consensus statement from NAIMS
J Oh, D Ontaneda, C Azevedo, EC Klawiter, M Absinta, DL Arnold, ...
Neurology 92 (11), 519-533, 2019
672019
Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
AJ Solomon, R Watts, D Ontaneda, M Absinta, P Sati, DS Reich
Multiple Sclerosis Journal 24 (6), 750-757, 2018
622018
系统目前无法执行此操作,请稍后再试。
文章 1–20